COPYRIGHT© Jilin Zixin Pharmaceutical Industrial Co.,Ltd.

COPYRIGHT© 2018  吉林紫鑫药业股份有限公司

Jilin Zixin Pharmaceutical Co., Ltd. Announcement on the Dissolution of Shareholder Equity and Re-Pledge

Page view

Stock code: 002118 Securities abbreviation: Zixin Pharmaceutical Announcement No.: 2013-004

Jilin Zixin Pharmaceutical Co., Ltd.

Announcement on the dissolution of shareholder pledge and re-pledge

 

 

The company and all members of the board of directors guarantee that the content of the information disclosure is true, accurate and complete, and there are no false records, misleading statements or major omissions.

 

On January 24, 2013, the company received the controlling shareholder Dunhua Kangping Investment Co., Ltd. (hereinafter referred to as Kangping Company) Notice: Kangping Company pledges to Jilin Bank Co., Ltd. Changchun Ruixiang Sub-branch on January 18, 2012 (hereinafter referred to as : Ruixiang Branch) The company's unrestricted tradable shares of 16,430,000 shares (accounting for 3.20% of the company's total share capital, accounting for 6.53% of the company's shares held by Kangping) on January 23, 2013 at China Securities Depository and Clearing Co., Ltd. Shenzhen The branch handled the pledge registration formalities. On the same day, Kangping Company re-plied the above shares to Ruixiang Sub-branch and went through the pledge registration formalities at China Securities Depository and Clearing Co., Ltd. Shenzhen Branch. The pledge period began on January 23, 2013, until the pledgee handled the pledge registration. The day of the procedure.

As of the date of this announcement, Kangping Company has pledgeed 250,680,000 shares of the Company (accounting for 99.68% of the shares held by Kangping Company), accounting for 48.87% of the company's total share capital.

Special announcement.

Jilin Zixin Pharmaceutical Co., Ltd.

Board of Directors

January 25, 2013